Compare Stocks

DXI Energy Inc. acquires, explores for, and develops energy projects with a focus on oil and gas exploration in Canada and the United States. It holds interests in the Kokopelli project that covers an area of approximately 7,100 square miles with reserves of coal, oil shale, and natural gas located in Piceance Basin, Western Colorado; and Woodrush project consisting of 13,093 net acres situated in the Peace River Arch of British Columbia and Alberta. The company was formerly known as Dejour Energy Inc. and changed its name to DXI Energy Inc. in October 2015. DXI Energy Inc. was incorporated in 1968 and is headquartered in Vancouver, Canada.

Marquee Energy Ltd., a junior energy Company, focuses on the acquisition, exploration, development, and production of oil and natural gas properties in Alberta, Canada. The company primarily has a 100% interest in the Michichi area covering an area of 212,187 acres located in eastern Alberta. As of March 7, 2017, it had proved plus probable reserves of 22.6 million barrels of oil equivalent. The company is headquartered in Calgary, Canada.

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.

Zendesk, Inc., a software development company, provides software as a service solutions for organizations in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. Its flagship product is Zendesk Support, a system for tracking, prioritizing, and solving customer support tickets across various channels. The company also offers Zendesk Chat, a live chat and messaging software to connect with customers on websites and mobile devices applications; Zendesk Talk, a cloud-based call center software; Zendesk Guide, a knowledge base that powers customer self-service and support agent productivity; Zendesk Gather, a community forum software that allows customer end-users to connect and collaborate; Zendesk Explore, which provides analytics for organizations to measure and enhance the customer experience; and Zendesk Sell, a sales customer relationship management (CRM) product solution to enhance productivity, processes, and pipeline visibility. In addition, it provides Zendesk Sunshine, a CRM platform; Sunshine Conversations, a messaging platform solution; Zendesk Developer Tools, a combination of application programming interfaces, web widget, and mobile software development kits; Zendesk APIs that allow users to build custom integrations and interact with Zendesk data; and Zendesk Apps that enable organizations to customize Zendesk product and platform solution interfaces and optimize workflow through plug-ins, as well as Zendesk Suite, an omnichannel offering, which combines its solutions. The company was founded in 2007 and is headquartered in San Francisco, California.